Prosoma: Funding, Investors & Team (Sep 2026)
Prosoma is a medical company creating digital therapeutics products for cancer patients. We develop a portfolio of digital therapeutics medical software products that cover the entirety of behavioural treatment needs of cancer patients. Our clinically validated platform is set to be prescribed by doctors and therapists in Germany, and it will be reimbursed by the local healthcare system in 2022. We aim to become #1 global digital therapeutics solution for oncology and we have a pathway to get there. Prosoma’s “Software as a Medical Device” platform is a set of stand-alone apps tailored to the different stages of the patient’s journey, which includes: symptoms and treatment support, psycho-social support, and behavioural support. All of these pathways are clinically validated and accessible at any time and anywhere the patient needs it. Our medical self-care applications are designed to deliver therapeutic methods personalised to each patient based on their diagnosis and outcomes. It is the most comprehensive toolset to make patient’s life better. Prosoma is developed by medical experts and patients. We partner with the most renowned organisations for the clinical trials, as well as, large scale commercial partners in the USA and Germany. We are a part of various acceleration programmes such as: Accelerate Cambridge, Incredibles, and the HealthHub at the University of California. Prosoma is being developed and built to meet EU Medical Device Regulations: ISO 13485, ISO 62304, and ISO 27001. We are proud to be funded by a VC fund and Business Angels who support our vision and strategy. In 2020, Prosoma received an NCBiR grant for developing a COVID-19 centred product.
Prosoma has raised $7.8M across 4 funding rounds on record, the most recent a Series A announced in Jun 2025.
Prosoma Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Prosoma Funding Rounds
2 of 4 rounds were announced without a disclosed amount and are excluded from the total.
Prosoma raised $3.2M in a Series A announced in Dec 2022.
6 months later, an undisclosed round was announced in Jun 2023 with no disclosed amount.
1.6 years later, a Seed of $4.6M was announced in Jan 2025.
5 months later, a Series A was announced in Jun 2025 with no disclosed amount.
Prosoma Founders and Leadership Team
Contact details for the Prosoma team: 3 of 3 have an email address on file.
Start 14-day free trial →Prosoma Funding Compared to Other Health Care Startups
Funded Startups Like Prosoma in Health Care and Berlin
Companies Similar to Prosoma
Arab Therapy functions as a startup that focuses on mental health.
Intu Diagnostics develops rapid and instrument-free solutions for infectious disease diagnostics, aiming for…
Maple Aviation is a medical logistics startup that specializes in building and operating autonomous drone…
Regulate is a wellness and performance company that provides science-backed breathwork programs and a mobile…
Avelios is a modular clinic platform that digitizes and optimizes all clinic processes in a user-friendly…
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary…
XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and…
Wellster is the go-to solution for everyday consumer health. It builds digital clinics along the lifecycle of…
Berlin Heals Holding is a developer of implantable medical device for the cure of heart failure.
Recare is reevaluating the process of discharge management by utilizing digital tools to improve…
Altavo operates as a medical device startup. Altavo harness the power of machine learning and…
Mallia Innovations specializes in creating evidence-based hair regeneration solutions that target specific…
Prosoma Funding FAQs
What does Prosoma do?
Prosoma is a medical company creating digital therapeutics products for cancer patients. We develop a portfolio of digital therapeutics medical software products that cover the entirety of behavioural treatment needs of cancer patients. Our clinically validated platform is set to be prescribed by doctors and therapists in Germany, and it will be reimbursed by the local healthcare system in 2022. We aim to become #1 global digital therapeutics solution for oncology and we have a pathway to get there. Prosoma’s “Software as a Medical Device” platform is a set of stand-alone apps tailored to the different stages of the patient’s journey, which includes: symptoms and treatment support, psycho-social support, and behavioural support. All of these pathways are clinically validated and accessible at any time and anywhere the patient needs it. Our medical self-care applications are designed to deliver therapeutic methods personalised to each patient based on their diagnosis and outcomes. It is the most comprehensive toolset to make patient’s life better. Prosoma is developed by medical experts and patients. We partner with the most renowned organisations for the clinical trials, as well as, large scale commercial partners in the USA and Germany. We are a part of various acceleration programmes such as: Accelerate Cambridge, Incredibles, and the HealthHub at the University of California. Prosoma is being developed and built to meet EU Medical Device Regulations: ISO 13485, ISO 62304, and ISO 27001. We are proud to be funded by a VC fund and Business Angels who support our vision and strategy. In 2020, Prosoma received an NCBiR grant for developing a COVID-19 centred product.
How much funding has Prosoma raised?
Prosoma has raised $7.8M across 4 rounds on record.
When did Prosoma last raise funding?
Prosoma's most recent funding round on record was announced in Jun 2025. The amount was not disclosed.
Who founded Prosoma?
FundedIQ lists Andrzej Jonczyk (Founder), Ema Kufel (Founder), Piotr Grudzinski (Founder) at Prosoma.
Where is Prosoma headquartered?
Prosoma is based in Berlin, Germany.
How many employees does Prosoma have?
Prosoma is in the 11-50 employee band.
About FundedIQ's Prosoma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Prosoma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.